StemCells,_Inc.

StemCells, Inc.

StemCells, Inc.

Public biopharmaceutical company headquartered in Newark, California

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.[1][2]

Quick Facts Company type, Industry ...

They are being studied in early stage trials.[3][4]

In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.[5]

References

  1. [1]
    Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."
  2. [2]
    Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
  3. [3]
    http://www.clinicaltrials.gov/ct2/show/NCT02163876
  4. [4]
    "StemCells Inc says spinal injury therapy shows promise". Reuters. 2015-11-18. Retrieved 2015-12-23.
  5. [5]
    "Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer". BioSpace. Retrieved 2020-03-03.
Share this article:

This article uses material from the Wikipedia article StemCells,_Inc., and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.